Telix Pharmaceuticals Statistics
Total Valuation
TLX has a market cap or net worth of $3.25 billion. The enterprise value is $3.60 billion.
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TLX has 338.78 million shares outstanding. The number of shares has decreased by -2.12% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 338.78M |
| Shares Change (YoY) | -2.12% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 14.72% |
| Owned by Institutions (%) | 45.44% |
| Float | 273.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 483.50 |
| PS Ratio | 4.05 |
| Forward PS | n/a |
| PB Ratio | 7.83 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.48 |
| EV / EBITDA | 110.87 |
| EV / EBIT | 186.60 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 1.12.
| Current Ratio | 1.43 |
| Quick Ratio | 1.21 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | 11.61 |
| Debt / FCF | n/a |
| Interest Coverage | 1.40 |
Financial Efficiency
Return on equity (ROE) is -1.85% and return on invested capital (ROIC) is 2.60%.
| Return on Equity (ROE) | -1.85% |
| Return on Assets (ROA) | 1.15% |
| Return on Invested Capital (ROIC) | 2.60% |
| Return on Capital Employed (ROCE) | 2.07% |
| Weighted Average Cost of Capital (WACC) | 7.14% |
| Revenue Per Employee | $678,880 |
| Profits Per Employee | -$6,018 |
| Employee Count | 1,184 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 13.90 |
Taxes
In the past 12 months, TLX has paid $1.86 million in taxes.
| Income Tax | 1.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.16% in the last 52 weeks. The beta is 0.65, so TLX's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -43.16% |
| 50-Day Moving Average | 9.97 |
| 200-Day Moving Average | 9.31 |
| Relative Strength Index (RSI) | 36.96 |
| Average Volume (20 Days) | 121,108 |
Short Selling Information
The latest short interest is 270,088, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 270,088 |
| Short Previous Month | 390,717 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.10% |
| Short Ratio (days to cover) | 1.27 |
Income Statement
In the last 12 months, TLX had revenue of $803.79 million and -$7.13 million in losses. Loss per share was -$0.02.
| Revenue | 803.79M |
| Gross Profit | 381.85M |
| Operating Income | 19.29M |
| Pretax Income | -5.27M |
| Net Income | -7.13M |
| EBITDA | 32.46M |
| EBIT | 19.29M |
| Loss Per Share | -$0.02 |
Full Income StatementBalance Sheet
The company has $141.87 million in cash and $467.11 million in debt, with a net cash position of -$325.24 million or -$0.96 per share.
| Cash & Cash Equivalents | 141.87M |
| Total Debt | 467.11M |
| Net Cash | -325.24M |
| Net Cash Per Share | -$0.96 |
| Equity (Book Value) | 415.38M |
| Book Value Per Share | 1.23 |
| Working Capital | 98.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.29 million and capital expenditures -$25.69 million, giving a free cash flow of -$42.99 million.
| Operating Cash Flow | -17.29M |
| Capital Expenditures | -25.69M |
| Depreciation & Amortization | 13.17M |
| Net Borrowing | -5.53M |
| Free Cash Flow | -42.99M |
| FCF Per Share | -$0.13 |
Full Cash Flow StatementMargins
Gross margin is 47.51%, with operating and profit margins of 2.40% and -0.89%.
| Gross Margin | 47.51% |
| Operating Margin | 2.40% |
| Pretax Margin | -0.66% |
| Profit Margin | -0.89% |
| EBITDA Margin | 4.04% |
| EBIT Margin | 2.40% |
| FCF Margin | n/a |
Dividends & Yields
TLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.12% |
| Shareholder Yield | 2.12% |
| Earnings Yield | -0.22% |
| FCF Yield | -1.32% |
Analyst Forecast
The average price target for TLX is $21.10, which is 216.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.10 |
| Price Target Difference | 216.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TLX has an Altman Z-Score of 4.4 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.4 |
| Piotroski F-Score | 1 |
